[go: up one dir, main page]

AU6496094A - Tumor-associated antigens recognized by t cells and the uses of these antigens - Google Patents

Tumor-associated antigens recognized by t cells and the uses of these antigens

Info

Publication number
AU6496094A
AU6496094A AU64960/94A AU6496094A AU6496094A AU 6496094 A AU6496094 A AU 6496094A AU 64960/94 A AU64960/94 A AU 64960/94A AU 6496094 A AU6496094 A AU 6496094A AU 6496094 A AU6496094 A AU 6496094A
Authority
AU
Australia
Prior art keywords
antigens
tumor
cells
recognized
associated antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64960/94A
Inventor
Herman N Eisen
Edward B Reilly
Theodore Tsomides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU6496094A publication Critical patent/AU6496094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU64960/94A 1993-03-31 1994-03-31 Tumor-associated antigens recognized by t cells and the uses of these antigens Abandoned AU6496094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4080093A 1993-03-31 1993-03-31
US040800 1993-03-31
PCT/US1994/003507 WO1994023067A1 (en) 1993-03-31 1994-03-31 Tumor-associated antigens recognized by t cells and the uses of these antigens

Publications (1)

Publication Number Publication Date
AU6496094A true AU6496094A (en) 1994-10-24

Family

ID=21913036

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64960/94A Abandoned AU6496094A (en) 1993-03-31 1994-03-31 Tumor-associated antigens recognized by t cells and the uses of these antigens

Country Status (2)

Country Link
AU (1) AU6496094A (en)
WO (1) WO1994023067A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660276B1 (en) 1994-02-16 2003-12-09 The University Of Virginia Patent Foundation Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
CA2188432C (en) 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
US5843648A (en) * 1995-01-10 1998-12-01 The United States Of America As Represented By The Secretary, Department Of Health And Human Services P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US6951917B1 (en) 1995-09-26 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services MHC-class II restricted melanoma antigens and their use in therapeutic methods
US7501501B2 (en) 1995-09-26 2009-03-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services MHC-Class II restricted melanoma antigens and their use in therapeutic methods
AU3036597A (en) * 1996-05-21 1997-12-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
US6733764B2 (en) * 2000-06-14 2004-05-11 Alain Martin Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer

Also Published As

Publication number Publication date
WO1994023067A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
AU4152293A (en) Closure
IL111926A0 (en) Humanized antibodies and uses thereof
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU4596093A (en) Composite materials and methods for making the same
AU7949394A (en) Reconstituted human antibody against human medulloblastomatous cell
AU7465794A (en) Probiotics
AU7422496A (en) NM03 antibody materials and methods
EP0801331A3 (en) Electrophotosensitive material
AU6775894A (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU6899994A (en) Novel macrolides and the use thereof
AU1099597A (en) Novel xylanases and uses thereof
AU6889794A (en) Water-repellent earth material, and methods of making and using the same
AU7180294A (en) Reaction cell for protein sequencer and the like
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
AU5294993A (en) Epidermal surface antigen and uses thereof
AU5255493A (en) Viable cell-containing preparation and the preparation method thereof
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
AU5371694A (en) Use of the tarchonanthus camphoratus
AU3286993A (en) Explosive composition, manufacture and use thereof
AU6428694A (en) Multiply-coated particles
AU3895593A (en) Biocatalysis
AU5609694A (en) Melanogenic inhibitor, and methods of producing and using the same
AU6977894A (en) Storage of antibodies
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same